TRCT
VCYT icon

Tower Research Capital (TRC)’s Veracyte VCYT Stock Holding History

Tower Research Capital (TRC)’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$239K Buy
7,414
+6,173
+497% +$229K 0.01% 1483
2025
Q4 		$52.2K Sell
1,241
-25,748
-95% -$1.04M ﹤0.01% 2387
2025
Q3 		$927K Buy
26,989
+7,788
+41% +$223K 0.03% 546
2025
Q2 		$519K Buy
19,201
+15,371
+401% +$445K 0.01% 952
2025
Q1 		$114K Sell
3,830
-1,635
-30% -$62.3K ﹤0.01% 1707
2024
Q4 		$216K Buy
5,465
+3,650
+201% +$138K ﹤0.01% 1660
2024
Q3 		$61.8K Sell
1,815
-6,878
-79% -$193K ﹤0.01% 2601
2024
Q2 		$188K Buy
8,693
+6,932
+394% +$146K ﹤0.01% 2121
2024
Q1 		$39K Sell
1,761
-15,497
-90% -$378K ﹤0.01% 2443
2023
Q4 		$475K Buy
17,258
+14,712
+578% +$355K 0.01% 1402
2023
Q3 		$56.9K Sell
2,546
-1,700
-40% -$43.7K ﹤0.01% 2434
2023
Q2 		$108K Sell
4,246
-1,514
-26% -$36.7K ﹤0.01% 1969
2023
Q1 		$128K Buy
5,760
+3,863
+204% +$93.4K ﹤0.01% 1648
2022
Q4 		$45K Sell
1,897
-42,391
-96% -$985K ﹤0.01% 2437
2022
Q3 		$735K Buy
44,288
+36,136
+443% +$813K 0.01% 862
2022
Q2 		$162K Buy
8,152
+7,062
+648% +$143K ﹤0.01% 1930
2022
Q1 		$30K Buy
1,090
+421
+63% +$12K ﹤0.01% 3161
2021
Q4 		$27K Sell
669
-71
-10% -$3.14K ﹤0.01% 3356
2021
Q3 		$34K Sell
740
-1,086
-59% -$47.4K ﹤0.01% 3271
2021
Q2 		$73K Sell
1,826
-39,047
-96% -$1.67M ﹤0.01% 2694
2021
Q1 		$2.2M Buy
40,873
+37,247
+1,027% +$2.15M 0.04% 447
2020
Q4 		$177K Buy
3,626
+1,422
+65% +$65.9K 0.01% 1816
2020
Q3 		$72K Sell
2,204
-6,368
-74% -$202K ﹤0.01% 3377
2020
Q2 		$222K Buy
+8,572
New +$214K 0.01% 1707
2020
Q1 		– Sell
-783
Closed -$22K – 3942
2019
Q4 		$22K Sell
783
-367
-32% -$9.5K ﹤0.01% 1869
2019
Q3 		$28K Buy
1,150
+1,075
+1,433% +$28.6K ﹤0.01% 2236
2019
Q2 		$2K Sell
75
-509
-87% -$12.7K ﹤0.01% 3323
2019
Q1 		$15K Sell
584
-2,750
-82% -$52.5K ﹤0.01% 2447
2018
Q4 		$42K Sell
3,334
-9,306
-74% -$110K ﹤0.01% 1404
2018
Q3 		$121K Buy
12,640
+10,732
+562% +$118K 0.01% 1242
2018
Q2 		$18K Sell
1,908
-3,034
-61% -$21.3K ﹤0.01% 2502
2018
Q1 		$28K Sell
4,942
-8,073
-62% -$50K ﹤0.01% 2003
2017
Q4 		$85K Buy
13,015
+9,480
+268% +$70.5K 0.01% 972
2017
Q3 		$31K Sell
3,535
-7,372
-68% -$60K ﹤0.01% 2420
2017
Q2 		$91K Buy
10,907
+10,807
+10,807% +$88.2K 0.01% 533
2017
Q1 		$1K Sell
100
-486
-83% -$3.98K ﹤0.01% 2860
2016
Q4 		$5K Buy
+586
New +$4.38K ﹤0.01% 3074
2016
Q3 		– Sell
-372
Closed -$2K – 4490
2016
Q2 		$2K Buy
+372
New +$2K ﹤0.01% 3971
2016
Q1 		– Sell
-390
Closed -$3K – 4987
2015
Q4 		$3K Sell
390
-3,781
-91% -$25.5K ﹤0.01% 3526
2015
Q3 		$20K Buy
4,171
+3,033
+267% +$28.9K ﹤0.01% 1741
2015
Q2 		$12K Buy
+1,138
New +$11.2K ﹤0.01% 2550
2014
Q4 		– Sell
-518
Closed -$5K – 4730
2014
Q3 		$5K Buy
518
+113
+28% +$1.48K ﹤0.01% 3322
2014
Q2 		$7K Buy
405
+333
+463% +$4.79K ﹤0.01% 2641
2014
Q1 		$1K Sell
72
-528
-88% -$8.43K ﹤0.01% 4218
2013
Q4 		$9K Buy
+600
New +$7.81K ﹤0.01% 3108

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Tower Research Capital (TRC)'s VCYT Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Veracyte (VCYT) stake by 497% in Q1 2026, buying an estimated $229K and bringing the position to 7,414 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #1483.

Tower Research Capital (TRC) first reported a position in VCYT in Q4 2013 and has held it in 45 quarters since. The position peaked at $2.2M in Q1 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Tower Research Capital (TRC) held 7,414 shares of Veracyte worth $239K as of Q1 2026.
  • Tower Research Capital (TRC) bought 6,173 Veracyte shares in Q1 2026, an estimated $229K.
  • Veracyte made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1483 holding.
  • Tower Research Capital (TRC) first reported a position in Veracyte in Q4 2013 and has held it in 45 quarters since.
  • Tower Research Capital (TRC)'s Veracyte position peaked at $2.2M in Q1 2021.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.